Jean-Philippe Couderc, PhD, MBA is an internationally recognized authority in the development of computerized technologies related to cardiac safety. He was the scientific founder and the CTO of iCardiac Technologies Inc. a startup company delivering high-precision biomarkers to pharmaceutical companies. iCardiac was purchased by eRT in Dec. 2017. Dr. Couderc research work has been highlighted by major media including the Wall Street Journal.

Dr. Hall is an expert in complete management of pacemakers, defibrillators, and resynchronization devices. He specializes in treatment of patients with atrial fibrillation, especially ablation for atrial fibrillation. He is board certified in Internal Medicine, Cardiovascular Disease and Clinical Cardiac Electrophysiology. Dr. Hall graduated from Emory University in 1992, received his MD from the URMC in 1997.

Alex Zapesochny co-founded iCardiac Technologies in 2006, which commercialized technologies from the University of Rochester and from Pfizer for better determining whether pharmaceutical products are safe for the heart. The company went on to serve the largest global pharma companies. iCardiac was acquired by the private equity firm Norwest Venture Partners in 2014 and then was acquired in late 2017 by ERT (owned by Nordic Capital).

Gill Tsouri received his PhD degree in Electrical and Computer Engineering from Ben-Gurion University (Israel). His research encompassed Wireless Communications and Signal Processing. From 1998 to 2002 he was with Yitran Communications, where he developed cutting edge power-line communication technologies. His past entrepreneurship experience includes developing a novel drip irrigation technology and licensing it to Rivulis Irrigation.